Unveiling the influence of tumor microenvironment and spatial heterogeneity on temozolomide resistance in glioblastoma using an advanced human in vitro model of the blood-brain barrier and glioblastoma
Glioblastoma (GBM) is the most common primary malignant brain cancer in adults with a dismal prognosis. Temozolomide (TMZ) is the first-in-line chemotherapeutic; however, resistance is frequent and multifactorial. While many molecular and genetic factors have been linked to TMZ resistance, the role...
Saved in:
Main Authors: | Lam, Maxine S. Y., Aw, Joey J. Y., Tan, Damien, Vijayakumar, Ragavi, Lim, Grace Hui Yi, Yada, Swathi, Pang, Qing You, Barker, Nick, Tang, Carol, Ang, Beng Ti, Sobota, Radoslaw M., Pavesi, Andrea |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Article |
Language: | English |
Published: |
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/174305 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide
by: Cheng, Hong Sheng, et al.
Published: (2024) -
Improved median survival for glioblastoma multiforme following introduction of adjuvant temozolomide chemotherapy
by: Back, M.F., et al.
Published: (2016) -
Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma
by: Justyna Magdalena Przystal, et al.
Published: (2019) -
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of Integrin-linked kinase (ILK)
by: Edwards, L.A., et al.
Published: (2014) -
Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme
by: Lim, Xin Yuan, et al.
Published: (2023)